597 results on '"Gilon P"'
Search Results
152. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway
153. Ventricular Septal Defect as a Complication of TAVI: Mechanism and Incidence
154. Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan – How to Do it Yourself!
155. Cardiac structure and function predicts functional decline in the oldest old
156. In Defense of Metrics: Metrics Sufficiently Encode Typical Human Preferences Regarding Hydrological Model Performance
157. PO16 Le tolbutamide contrôle la sécrétion de glucagon d’îlots de souris différemment du glucose : rôle des canaux KATP des cellules α et δ
158. Shock complicating type A acute aortic dissection: Clinical correlates, management, and outcomes.
159. Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells.
160. H19non-coding RNA in urine cells detects urothelial carcinoma: a pilot study
161. O55 Amplification de la sécrétion d’insuline par le glucose : augmentation du Ca2+ sous-membranaire dans les cellules β ou augmentation de l’action Ca2+
162. Research study of some RAM antennas Final report, 18 Nov. 1964 - 18 Jun. 1965
163. Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart
164. Acute Aortic Syndromes: Surveillance with Imaging.
165. Pneumococcal infection of a prosthetic hip joint
166. Glucose inhibits glucagon secretion by decreasing [Ca2+]c and by reducing the efficacy of Ca2+ on exocytosis via somatostatin-dependent and independent mechanisms.
167. Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic -Cell Function
168. The Molecular Basis of Neural Memory. Part 4. “Binary” Computation vs “Multinary” Mentation
169. Systematic solid-phase synthesis of linear pseudooligolysines containing multiple adjacent CH<SUB>2</SUB>NH amide bond surrogates: potential agents for gene delivery
170. Calcium signaling in pancreatic β-cells in health and in Type 2 diabetes.
171. Oscillations of insulin secretion can be triggered by imposed oscillations of cytoplasmic Ca2+ or metabolism in normal mouse islets.
172. Multiple sites of purinergic control of insulin secretion in mouse pancreatic beta-cells.
173. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
174. Is It Time to Revise the Guidelines and Recommendations for Digital Echocardiography?
175. Temporal and quantitative correlations between insulin secretion and stably elevated or oscillatory cytoplasmic Ca2+ in mouse pancreatic beta-cells
176. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
177. Abstract 10188: Does Myocardial Contraction Fraction Predict Mortality in the Oldest Old
178. G protein-dependent inhibition of L-type Ca2+ currents by acetylcholine in mouse pancreatic B-cells.
179. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.
180. No evidence for a role of reverse Na(+)-Ca2+ exchange in insulin release from mouse pancreatic islets
181. Ketoisocaproic acid and leucine increase cytoplasmic pH in mouse pancreatic B cells: role of cytoplasmic Ca2+ and pH-regulating exchangers.
182. Distinct effects of glucose on the synchronous oscillations of insulin release and cytoplasmic Ca2+ concentration measured simultaneously in single mouse islets.
183. Role of cyclic GMP in the control of capacitative Ca2+ entry in rat pancreatic acinar cells
184. Muscarinic stimulation exerts both stimulatory and inhibitory effects on the concentration of cytoplasmic Ca2+ in the electrically excitable pancreatic B-cell
185. Myocardial Dysfunction in Severe Sepsis and Septic Shock
186. Self-Assembled Metallic Nanowire-Based Vertical Organic Field-Effect Transistor
187. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets
188. Le contrôle de la sécrétion d'insuline par le glucose: signaux déclenchants et amplificateurs
189. Culture duration and conditions affect the oscillations of cytoplasmic calcium concentration induced by glucose in mouse pancreatic islets
190. The role of protein kinase-C in signal transduction through vasopressin and acetylcholine receptors in pancreatic B-cells from normal mouse.
191. Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells
192. Two sites of glucose control of insulin release with distinct dependence on the energy state in pancreatic B-cells
193. Post-Procedural Hypertension Following Transcatheter Aortic Valve Implantation: Incidence and Clinical Significance.
194. Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets.
195. Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B cells.
196. Activation of muscarinic receptors increases the concentration of free Na+in mouse pancreatic B-cells
197. Polydepsippeptide. 4. Mitt Synthese der alternierenden Polydepsipeptide Poly(Ala-Lac) und Poly(Val-Lac)
198. Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell.
199. Evidence that glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells.
200. Intestinal Permeability of Cyclic Peptides: Common Key Backbone Motifs Identified.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.